Health officials urge Michiganders to take precautions to prevent tick bites as the blood-sucking arachnids spread to more ...

A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...

Elon Musk this week amplified an unfounded claim, based on a distortion of vaccine safety monitoring data, that COVID-19 ...

Beginning in 2023, Novavax embarked on an identity shift, moving away from the fully integrated business ambitions once fueled by a pandemic-era gold rush in vaccines toward a leaner structure built ...

Pfizer (PFE) and BioNTech (BNTX) have halted recruitment for a large U.S.-based clinical trial designed to test their updated COVID-19 vaccine in healthy adults aged 50-64 years, citing challenges in ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: An illustration photo shows a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from Skippack ...

LONDON, April 1 (Reuters) - Vaccine makers Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug program. But for Valneva CEO Thomas Lingelbach, the regulatory future of the ...

FILE PHOTO: A person poses with a dose of Pfizer COMIRNATY (COVID-19 Vaccine, mRNA) in this illustration picture taken in Schwenksville, Pennsylvania, U.S. September 24, 2025. REUTERS/Hannah Beier ...

CHICOPEE, Mass. (WWLP) – Biotech companies Valneva and Pfizer announced results from the Phase three trial of a Lyme disease vaccine candidate that shows more than 70% efficiency in preventing the ...

Pfizer shared an update last week on its clinical trial for VALOR, which is short for "Vaccine Against Lyme for Outdoor Recreationists." The drugmaker said in its report that the vaccine was ...

ROANOKE, Va. (WDBJ) - Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease. Vaccines for Lyme disease have had a troubled past. One was approved in 1998. Its manufacturer ...